Navigation Links
Newport Board Group, a National Business Advisory Firm of CEOs Serving the Emerging Middle Market, Releases a Technology Roadmap for Private Companies
Date:5/6/2013

e greater scale with fewer employees and little capital investment; cost is “by the drink”
  •     Go global at an earlier stage by deploying Software-as-a-Service (SaaS) and Platform-as-a-Service (PaaS) technology not previously available to mid-sized companies
  •     Deploy on-line CRM and customer care to "re-personalize" customers’ experience and make relationships more “sticky”
  •     Use technology to bridge the gap between offline and online worlds
  • Private companies have an opportunity to compete more effectively with larger companies and level the playing field by deploying information technology that helps reach the market and operate more efficiently. Smart deployment of these emerging information technologies does not require large capital expenditures or expensive technical staff. Catching up will require judicious use of business consultants well-versed in applying these technologies and marketing strategies to the world of mid-market companies. There is no better time than the present to harness the power of technology to propel your company forward.

    Newport Board Group is a partnership of board directors and senior executive leaders. We assist growth, middle market and private equity portfolio companies to navigate transitions and improve performance.

    Michael Evans ((415) 990-1844) is Managing Director of the Northern California practice of the Newport Board Group.
    Farhat Ali ((408) 623-2800) is a partner in the Northern California practice of the Newport Board Group.

    Read the full story at http://www.prweb.com/releases/2013/5/prweb10691378.htm.


    '/>"/>
    Source: PRWeb
    Copyright©2012 Vocus, Inc.
    All rights reserved

    Page: 1 2 3

    Related medicine news :

    1. Private Companies Will Face Increased Competition for Sales in 2013 - Newport Board Group Releases Seven Strategies Designed to Improve Customer Retention
    2. d'Oliveira & Associates Helps Newport Woman Receive $150,000 Settlement for Auto Accident; Case: MI-11889
    3. iPad Mini Leather Keyboard Portfolio Combines Protection with Easy Typing
    4. Gregory T. Kaiser, Vice President, Universal Orlando Resort, Joins Camp Boggy Creek Board of Directors
    5. Bob Fitzmaurice to Join Board of Directors at Expaticore
    6. iPad Leather Portfolio Offers Awesome Protection with Built-in Keyboard
    7. TekLink International Inc. and Reboard GmbH Announce Strategic Partnership Providing Mobility Solutions
    8. Bend, Oregon Resident Named to Board of Directors and Elected Vice-Chairman of Buteyko Breathing Educators Association
    9. iGear's New Ultrathin iPad Aluminum Bluetooth Keyboard Case Rocks on Amazon.com
    10. New Ultrathin iPad Aluminum Bluetooth Keyboard Case Rocks on Ebay
    11. New iPad Bluetooth Keyboard Leather Portfolio Rocks on Amazon.com
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/21/2014)... Steven Reinberg HealthDay ... The number of U.S. teens using sunscreen dropped nearly 12 ... During that same time period, the number of teens using ... to use sunscreen increase the risk of skin cancers, including ... decrease in the overall percentage of teens who reported wearing ...
    (Date:8/21/2014)... St. Louis, MO (PRWEB) August 21, 2014 ... work in family and product liability law, announces the ... The website provides comprehensive information on morcellator surgery ... the April 2014 FDA morcellator cancer warning and the ... news release* accompanying the April 17, 2014 FDA warning ...
    (Date:8/21/2014)... announces the immediate release of Care of the ... CHEST Consensus Statement today in the Online First ... the global health-care community cares for patients with ... guide ethical decision-making, coordination of care, resource conservation, ... by over 100 clinicians and experts representing a ...
    (Date:8/21/2014)... international scientific collaboration led by Baylor College of Medicine ... to a rare form of kidney cancer, providing new ... types as well. , The collaboration, a project of ... initiative , completed the sequence of chromophobe renal cell ... Cancer Cell . , "The Cancer Genome ...
    (Date:8/21/2014)... have developed a genetically engineered line of mice that ... on epilepsy, Alzheimer,s and other diseases. , The ... of fluorescence in response to different calcium levels. This ... and microglia, to be studied in a new way. ... how the brain works," said Petr Tvrdik, Ph.D., ...
    Breaking Medicine News(10 mins):Health News:Fewer U.S. Teens Using Sunscreen, Study Finds 2Health News:The Onder Law Firm Launches National Morcellator Cancer Lawsuit Center Website for Morcellator Surgery Lawsuits at MorcellatorCancerLawsuitCenter.com 2Health News:The Onder Law Firm Launches National Morcellator Cancer Lawsuit Center Website for Morcellator Surgery Lawsuits at MorcellatorCancerLawsuitCenter.com 3Health News:CHEST releases new expert guidance in care of the critically ill and injured 2Health News:Sequence of rare kidney cancer reveals unique alterations involving telomerase 2Health News:Sequence of rare kidney cancer reveals unique alterations involving telomerase 3Health News:Mouse model for epilepsy, Alzheimer's gives window into the working brain 2
    ... who undergo heart surgery fare better if they receive ... ,Investigators say that children who received reconstituted ... cells and plasma -- tended to accumulate less fluid, ... the study, researchers compared results for 200 infants who ...
    ... the brain using the CyberKnife frameless radiosurgery can successfully ... CyberKnife is a non-invasive robotic radiosurgical device that can ... uses a robotic arm, controlled by a computer, that ... tumor site. ,During the study researchers examined ...
    ... are obese when they are diagnosed with early-stage breast cancer ... women of normal weight.// ,Studies in the past have ... development, and has also shown to have contradictory results about ... latest study researchers say, they have demonstrated a significant association ...
    ... is an often disabling condition that affects primarily women. ... cannot be overcome with rest and often worsens with ... and there are no diagnostic tests or cures. A ... are at increased risk for developing chronic fatigue later ...
    ... in restoring sudden onset hearing loss. Researchers say sudden hearing ... of the sudden hearing loss can be identified in only ... includes viral and bacterial diseases, and metabolic, neurologic and immunologic ... which case there is no known cause. ,Previous research ...
    ... that affects more than 80 percent of teenagers and up ... cited // as a source of acne, these claims have ... this study. Each participant had at least one academic examination ... sources of stress for students. Stress levels were recorded using ...
    Cached Medicine News:
    (Date:8/21/2014)... , Aug. 21, 2014 /CNW/ - Bedrocan Cannabis Corp., ... independent members to its Board of Directors, enhancing ... of the company, a leading licensed producer of ... Internationally, Bedrocan has 13 years, experience in producing ... seven countries, including Canada. As ...
    (Date:8/21/2014)... CYBX ) today announced results for the quarter ended ... Operating results for the first quarter of fiscal ... other achievements, include: , Worldwide net product sales of ... net sales of $13.2 million, an increase of 14.5% on ... reached a new high of $58.8 million, an increase of ...
    (Date:8/21/2014)... MENLO PARK, Calif. , Aug. 21, 2014 /PRNewswire/ ... company in the emerging field of regenerative medicine, announced ... ("Nat") Ricciardi to the Company,s newly expanded Board of ... now comprises eight directors, three of whom are independent. ... years of experience working with emerging growth companies. He ...
    Breaking Medicine Technology:Senior Life Sciences Executives Join Bedrocan as Independent Directors 2Senior Life Sciences Executives Join Bedrocan as Independent Directors 3Cyberonics Reports Fiscal 2015 First Quarter Results 2Cyberonics Reports Fiscal 2015 First Quarter Results 3Cyberonics Reports Fiscal 2015 First Quarter Results 4Cyberonics Reports Fiscal 2015 First Quarter Results 5Cyberonics Reports Fiscal 2015 First Quarter Results 6Cyberonics Reports Fiscal 2015 First Quarter Results 7Cyberonics Reports Fiscal 2015 First Quarter Results 8Cyberonics Reports Fiscal 2015 First Quarter Results 9Cyberonics Reports Fiscal 2015 First Quarter Results 10Cyberonics Reports Fiscal 2015 First Quarter Results 11Cyberonics Reports Fiscal 2015 First Quarter Results 12Cyberonics Reports Fiscal 2015 First Quarter Results 13Cyberonics Reports Fiscal 2015 First Quarter Results 14Cyberonics Reports Fiscal 2015 First Quarter Results 15Cyberonics Reports Fiscal 2015 First Quarter Results 16Asterias Biotherapeutics Appoints Two Independent Directors and Announces Completion of Series A Common Stock Distribution 2Asterias Biotherapeutics Appoints Two Independent Directors and Announces Completion of Series A Common Stock Distribution 3Asterias Biotherapeutics Appoints Two Independent Directors and Announces Completion of Series A Common Stock Distribution 4
    ... 28, 2011 Tengion, Inc. (Nasdaq: TNGN ) ... to its Board of Directors. Mr. Flora brings to Tengion ... wound healing and surgical device businesses.  He most recently served ... Tengion also announced today that Gary Kurtzman, ...
    ... SOUTH SAN FRANCISCO, Calif., Sept. 28, 2011 Onyx ... that it has completed the New Drug Application (NDA) ... under the accelerated approval process for carfilzomib, a next ... with relapsed and refractory multiple myeloma. In addition, Onyx ...
    Cached Medicine Technology:Tengion Appoints Scott Flora to Board of Directors 2Tengion Appoints Scott Flora to Board of Directors 3Tengion Appoints Scott Flora to Board of Directors 4Onyx Pharmaceuticals Submits New Drug Application for Carfilzomib in Relapsed and Refractory Multiple Myeloma 2Onyx Pharmaceuticals Submits New Drug Application for Carfilzomib in Relapsed and Refractory Multiple Myeloma 3Onyx Pharmaceuticals Submits New Drug Application for Carfilzomib in Relapsed and Refractory Multiple Myeloma 4
    ...
    ...
    Bimanual I&A Cannulas. Curved 45 with a .51mm open-end irrigation port. Facilitates removal of cortical debris between 10-2 o'clock. .80mm x 17.0mm...
    ...
    Medicine Products: